David Liu, Ph.D., is a Principal at Vivo Capital with over 15 years of experience in Process R&D and CMC management in the pharmaceutical industry. He has led the development and implementation of novel and efficient chemical processes for many programs ranging from pre-IND to late stage development. Prior to Vivo, he worked at STA-WuXi Apptec as Executive Director of Process Research & Development. Prior to STA he was Director of Process Chemistry with Avista Pharma Solutions and Principal Research Investigator with Array BioPharma.

David received his B.S. and M.S. in Chemistry from Peking University and Ph.D. in Organic Chemistry from University of Pittsburgh. He completed his postdoctoral research at Texas A&M University.